Clinical Trial: rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Study Status: Completed
Recruit Status: RECRUITING
Condition: Prostate Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: A Pilot Study of rhPSMA-PET MRI Imaging for the Detection of Clinically Actionable Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Brief Summary:
This clinical trial evaluates whether positron emission tomography-magnetic resonance imaging (PET-MRI) using the radioactive drug radiohybrid prostate-specific membrane antigen (rhPSMA)-7.3 may help in detecting higher grade or stage disease in men with low and favorable intermediate risk prostate cancer who are candidates for active surveillance.A PET scan is a test that uses a radioactive drug and a computer to create images of how organs and tissues in the body are functioning.The radioactive drug used in this…
Read more